+ All Categories
Home > Documents > respiratory dis. Presentation1 for gen path.pptx

respiratory dis. Presentation1 for gen path.pptx

Date post: 14-Apr-2018
Category:
Upload: art-arts
View: 215 times
Download: 0 times
Share this document with a friend

of 123

Transcript
  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    1/123

    RESPIRATORYDISEASE

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    2/123

    Major Determinants of

    Disease Diseases of one lung compartment tend to affect

    the others

    The lungs are open to the environment, exposingthem to infectious agents, allergens, irritants, &carcinogens

    Most lung disease is caused by inhalation ofmaterial; the most common exception isautoimmune lung disease

    Lost pulmonary membrane is not recoverable

    Smoking is a major cause of lung disease The heart & lungs are a functional unit; lungdisease usually affects the heart; & heart diseaseusually affects the lungs

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    3/123

    Common Approach Affecting

    The airways The interstitium

    The pulmonary vascular system

    Chronic obstructive pulmonary disease(COPD)

    Acute lung injury

    Pulmonary infections Diffuse interstitial (restrictive, infiltrative)

    lung diseases

    Lung tumors

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    4/123

    Chronic Obstructive Pulmonary

    Diseases (COPD)

    Chronic bronchitis Emphysema

    Bronchiectasis

    Asthma

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    5/123

    Chronic B ronchi tis

    Chronic bronchitis is defined clinically. It is

    present in any patient who has persistent cough

    with sputum production for at least 3 months in

    at least 2 consecutive years, in the absence ofany other identifiable cause.

    (1) Progress to chronic obstructive airway

    disease (2) Lead to cor-pulmonale and heart failure

    (3) Cause atypical metaplasia and dysplasia of

    the respiratory epithelium

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    6/123

    Pathogenesis

    Tobacco smoke

    90% of patients are smokers.

    Grain, cotton, and silica dust Air pollution

    Infection

    Bacterial and viral infections are important

    intriggering acute exacerbation of the disease.

    Others

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    7/123

    Morphology Grossly

    Hyperemic and swollen Mucinous or mucopurulent secretions

    Histologically

    Chronic inflammation of the airways (predominantly

    lymphocytes) Enlargement of the mucus-secreting glands in the

    trachea and larger bronchi

    Inflammatory cells, largely mononuclear but

    sometimes admixed with neutrophils Goblet cell metaplasia, mucus plugging, inflammation,

    and fibrosis (small airway disease, (bronchiolitis

    obliterans)

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    8/123

    Chronic bronchitis. The lumen of the bronchus is above. Note the markedthickening of the mucous

    gland layer (approximately twice normal) and squamous metaplasia of lung

    epithelium. (From the teaching collection of the Department of Pathology,

    University of Texas, Southwestern Medical School,

    Dallas, Texas.)

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    9/123

    Clinical Course

    Prominent cough

    Production of sputum

    Hypercapnia, hypoxemia, and cyanosis

    Pulmonary hypertension and cardiac failure Recurrent infections and respiratory failure

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    10/123

    Complications

    Emphysema

    Cor pulmonale

    Bronchiectasis

    Bronchopneumonia

    Bronchogenic carcinoma of lung

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    11/123

    Emphysema

    Definition

    Emphysema is a condition of the lungcharacterized by abnormal permanent

    enlargement of the airspaces distal to the

    terminal bronchiole, accompanied bydestruction of their walls and without

    obvious fibrosis.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    12/123

    Pathogenesis

    The genesis of emphysema is not

    completely understood.

    A consequence of two critical imbalances

    The protease-antiprotease imbalance

    Oxidant-antioxidant imbalance

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    13/123

    Protease-An tip ro tease Imbalance

    Hypothesis

    Genetic deficiency of the antiprotease1- antitrypsin

    The effect of cigarette smoking in the

    development of emphysema Increased elastase availability and

    decreased

    antielastase activity occur in smokers. Smoking enhances elastase activity in

    macrophages

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    14/123

    Oxidant-Ant ioxidant Imbalance

    Tobacco smoke contains abundant

    reactive oxygen species (free radicals),

    which deplete these antioxidant

    mechanisms, thereby inciting tissue

    damage.

    Tissue breakdown is enhanced as a

    consequence of inactivation of protective

    antiproteases by reactive oxygen species

    in cigarette smoke.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    15/123

    Pathogenesis of emphysema. The protease-antiprotease

    imbalance andoxidant-antioxidant imbalance are additive in their effects and

    contribute to

    tissue damage.1-antitrypsin (1-AT) deficiency can be either

    congenital or

    "functional" as a result of oxidative inactivation.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    16/123

    Types of Emphysema

    According to its anatomic distribution within

    the lobule

    Four major types

    CentriacinarPanacinar

    Paraseptal

    Irregular Only the first two cause clinically significant

    airflow obstruction.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    17/123

    en tr iac inar (Centr i lobu lar)

    Emphysema

    The central or proximal parts of the acini,

    formed by respiratory bronchioles, are affected,

    whereas distal alveoli are spared. The lesions are more common and severe in

    the upper lobes, particularly in the apical

    segments. Centriacinar emphysema occurs

    predominantly in heavy smokers, often in

    association with chronic bronchitis.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    18/123

    Panacinar (Panlobular)

    Emphysema

    The acini are uniformly enlarged from the

    level of the respiratory bronchiole to the

    terminal blind alveoli. Tends to occur more commonly in the lower

    zones and in the anterior margins of the lung,

    and it is usually most severe at the bases. This type of emphysema is associated with

    1- antitrypsin (1-AT) deficiency.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    19/123

    A, Centriacinar emphysema. Central areas show

    marked emphysematous damage (E), surrounded byrelatively spared alveolar spaces.

    B, Panacinar

    emphysema involving the entire pulmonary

    architecture.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    20/123

    Distal Ac inar (Paraseptal)

    Emphysema

    The proximal portion of the acinus is normal,

    but the distal part is predominantly involved.

    The characteristic findings are of multiple,continuous, enlarged airspaces from less than

    0.5 cm to more than 2.0 cm in diameter,

    sometimes forming cystlike structures. This type of emphysema probably underlies

    many of the cases of spontaneous

    pneumothorax in young adults.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    21/123

    A irspace Enlargement w ith Fibros is

    (Irregular Emphysema)

    The most common form of emphysema

    Autopsy shows one or more scars from

    a healed inflammatory process.

    In most instances, these foci of irregular

    emphysema are asymptomatic and

    clinically insignificant.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    22/123

    In ters t i t ial Emphysema

    The entrance of air into the connective

    tissue stroma of the lung, mediastinum,

    orsubcutaneous tissue.

    Wound of the chest

    Children with whooping cough andbronchitis,

    Patients with obstruction to the airways

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    23/123

    Compensatory Hyper inf lat ion

    (Emphysema)

    Surgical removal of a diseased lung or

    lobe.

    Designate dilation of alveoli but not

    destruction of septal walls.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    24/123

    Bullous Emphysema

    Produces large subpleural blebs or

    bullae (spaces more than 1 cm in

    diameter in the distended state) Most often subpleural, and occur near

    the apex

    Pneumothorax

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    25/123

    Bullous emphysema with large subpleural

    bullae (upper left).

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    26/123

    Morphology

    The diagnosis and classification of emphysemadepend largely on the macroscopic appearance

    of the lung.

    Panacinar emphysema Produces pale, voluminous lungs that often obscure

    the heart when the anterior chest wall is removed at

    autopsy.

    Centriacinar emphysema

    The upper two-thirds of the lungs is more severely

    affected than the lower lungs.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    27/123

    Morphology

    DistalAcinar (Paraseptal) Emphysema

    Adjacent to the pleurabullae

    Spontaneous pneumothorax

    Irregular Emphysema

    The acinus is irregularly involved, is

    almost invariably associated with scarring

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    28/123

    Microscopy

    Thinning and destruction of alveolar

    walls

    Adjacent alveoli become confluent,creating large airspaces

    Loss of elastic tissue in the surrounding

    alveolar septa The number of alveolar capillaries is

    diminished.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    29/123

    Microscopically at high magnification, the loss of

    alveolar walls with emphysema is demonstrated.

    Remaining airspaces are dilated.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    30/123

    Clinical Course

    Dyspnea is usually the first symptom

    Steadily progressive Cough and wheezing

    Weight loss

    Pulmonary function tests The ratio of FEV1 to FVC is reduced

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    31/123

    Complications

    Cor pulmonale

    Pneumothorax

    Respiratory failure

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    32/123

    Anatomic distribution of pure chronic bronchitis and pure emphysema. In

    chronic bronchitis the small-airway disease (chronic bronchiolitis) results in

    airflow obstruction, while the large-airway disease is primarily responsible for

    the mucus hypersecretion.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    33/123

    Bronchiectasis

    The permanent dilation of bronchi and

    bronchioles caused by destruction of the

    muscle and elastic supporting tissue. Resulting from or associated with

    chronic necrotizing infections.

    Cough and expectoration of copiousamounts of purulent sputum

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    34/123

    Pathogenesis

    Obstruct ion

    Chronic pers istent in fect ion

    Damage to bronchial walls, leading to

    weakening and dilation.

    Obstructive secretions, inflammationthroughout the wall

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    35/123

    Morphology

    Affects the lower lobes bilaterally The airways dilated

    Histologically

    Intense acute and chronic inflammatoryexudate within the walls of the bronchi and

    bronchioles

    The desquamation of lining epitheliumcause extensive areas of ulceration

    Fibrosis of the bronchial and bronchiolar

    walls and peribronchiolar fibrosis

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    36/123

    This is the microscopic appearance of bronchiectasis.

    Bronchiectasis is not a specific disease, but a

    consequence of another disease process that destroys

    airways.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    37/123

    Clinical Course

    Severe, persistent cough with expectoration

    of mucopurulent

    Fetid, sputum.

    The sputum may contain flecks of blood

    Hypoxemia, hypercapnia, pulmonary

    hypertension, and (rarely) cor pulmonale.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    38/123

    Complications

    Lung abscess

    Pyemia--metastatic abscesses

    Pulmonary fibrosis

    Cor pulmonale

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    39/123

    Asthma

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    40/123

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    41/123

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    42/123

    Pathophysiology

    Asthma trigger

    - Inflammation & edema of the mucousmembranes.

    - Accumulation of tenacious secretionsfrom mucous glands.

    - Spasm of the smooth muscle of thebronchi & bronchioles decreasesthe caliber of the bronchioles.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    43/123

    Clinical manifestations

    A) General manifestations:

    1. The classical manifestations are: dyspnea,wheezing, & cough.

    2. The episode of asthma is usually beginswith the child feeling irritable &

    increasingly restless. Asthmatic child

    may complain headache, feeling tired, &

    chest tightness.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    44/123

    Clinical manifestations:

    B) Respiratory symptoms:

    - Hacking, paroxysmal, irritating and nonproductive cough due to bronchial edema.

    Accumulation of secretion stimulate cough thatbecomes rattling & productive (frothy, clear,gelatinous sputum).

    - Shortness of breath, prolonged expiration,wheezy chest, cyanosed nail beds, & dark redcolor lips that may progress by time to blue.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    45/123

    C) On chest examination:

    - Inspection reveals major changes in the form ofsupraclavicular, intercostals, subcostal, &

    sternal retractions due to the frequent use of

    accessory muscles of respiration.

    With repeated episodes: chest shape is changed

    to barrel chest, & elevated shoulder.

    - Auscultation reveals loud breath sounds in theform of course crackle, grunting, wheezes

    throughout the lung region.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    46/123

    Diagnostic evaluation:

    1. Clinical manifestations,history, physical examination,

    & Lab tests.

    2. Radiographic examination.

    3. Pulmonary function tests

    provide an objective method

    of evaluating the degree of

    lung disease.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    47/123

    Coughing

    Wheezing, a whistlingsound

    Shortness of breath

    Chest tightness

    Sneezing & runny

    nose

    Itchy and inflamed

    eyes

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    48/123

    Asthma

    Therapeutic

    management

    - Allergic control

    to preventattacks.

    Drug therapy:

    B- adrenergic,

    Theophyllin, &

    corticosteroids

    preparations + chest

    physiotherapy (onlyin between attacks).

    Clinical

    T

    Anatomic

    Sit

    Major

    P th l i

    Etiology Signs/

    S t

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    49/123

    Term Site Pathologic

    Changes

    Symptoms

    Chronic

    bronchitisBronchus Mucous gland

    hyperplasia,

    hypersecretion

    Tobacco

    smoke, air

    pollutants

    Cough,

    sputum

    production

    Bronchiectasis Bronchus Airway dilation

    and scarring

    Persistent or

    severe

    infections

    Cough,

    purulent

    sputum, fever

    Emphysema Acinus Airspace

    enlargement;

    wall

    destruction

    Tobacco

    smoke

    Dyspnea

    Asthma Bronchus Smooth

    muscle

    hyperplasia,

    excess mucus,

    inflammation

    Immunologic

    or undefined

    causes

    Episodic

    wheezing,

    cough,

    dyspnea

    Lower Respiratory Tract

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    50/123

    Lower Respiratory Tract

    Infections: Bronchiolitis (RSV

    Infection) 2-12 month Caused by syncytial virus Transmitted by oral droplet Predisposing factors (asthma, smoking) Causes necrosis and inflammation of small bronchi and

    bronchioles

    Signs Wheezing and dyspnea Rapid, shallow respirations Cough

    Rales

    Chest retractions Fever

    Treatment Supportive and symptomatic

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    51/123

    Pulmonary Infections

    Pneumonia can result

    whenever these defense

    mechanisms are impaired

    or whenever theresistance of the host in

    general is lowered.

    Most deadly infectious disease in the U.S.

    6th leading cause of death

    P i

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    52/123

    Pneumonia

    Etiological classification

    Bacterial pneumonia

    Viral pneumonia

    Fungal pneumoniaetc.

    Anatomical classification

    Lobar pneumoniaLobular pneumonia

    Interstitial pneumonia

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    53/123

    Pulmonary Infections or

    Pneumonia

    Pneumonia can be very broadly definedas any infection in the lung. It may

    present as acute, fulminant clinical

    disease or as chronic disease with amore protracted course.

    Pathogenesis

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    54/123

    Pathogenesis

    Streptoco ccus Pneumon iaeThe most common cause of acute pneumonia.

    Exam inat ion o f Gram -stained sputum is an important step

    in the diagnosis o f acute pneumon ia.

    Pneumococcal pneumonias respond readily to penicillin

    treatment, but there are increasing numbers of

    penicillinresistant

    strains of pneumococci.

    Haemoph i lus Inf luenzae A major cause of life-threatening acute lower respiratory

    tract

    infections and meningitis in young children.

    Moraxella Catarrhal is

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    55/123

    Streptococcal pneumon iae,pneumococcal

    Infection localized in 1 or morelobes

    Congestion

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    56/123

    Inflammation andvascular congestion in

    alveolar wall

    Exudate forms in alveoli Interferes with oxygen

    diffusion

    Consolidation

    Neutrophils, RBCs, fibrinaccum in exudate Form solid mass

    RBCs break down,infection resolves

    Macrophages break downexudate

    Expectorated or resorbed

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    57/123

    Pleurae typically involved Infection in pleural cavity Emphysema

    Adhesions betweenmembranes

    Manifestations Sudden onset Systemic signs: high fever,

    chills, fatigue

    Dyspnea, tachycardia Pleuritic pain Rales Productive cough

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    58/123

    Lung cancer

    Lung cancer is currently the mostfrequently diagnosed major cancer in the

    world and the most common cause of

    cancer mortality worldwide. Cancer of the lung occurs most often

    between ages 40 and 70 years, with a

    peak incidence in the fifties or sixties.

    The 5-year rate for all stages combined is

    only 15%.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    59/123

    Cigarette smoking

    Passive smokingincreases the risk of

    developing lung cancer to

    approximately twicethat of nonsmokers.

    Industrial Hazards

    Air Pollution

    Molecular Genetics

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    60/123

    Squamous dysplasia

    and carcinoma in situ

    Atypical adenomatous

    hyperplasia

    Diffuse idiopathic

    pulmonary

    neuroendocrine cellhyperplasia

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    61/123

    Squamous cell

    carcinoma (25% to

    40%)

    Adenocarcinoma

    (25% to 40%)

    Small cell carcinoma

    (20% to 25%) Large cell carcinoma

    (10% to 15%)

    I idi

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    62/123

    Insidious onset Normally metastized

    before diagnosis 4 possible categoriesof signs of lung cancer

    Direct effects oftumorSystemic effects ofcancer

    Paraneoplasticsyndromes

    Metastizes at othersites

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    63/123

    Persistent, productivecough, dyspnea,

    wheezing Detection on chest X-ray Hemoptysis

    Pleural involvement Chest pain Hoarseness

    Facial, arm edema;headaches Dysphagia

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    64/123

    Systemic signsWt. loss, anemia,

    fatigue

    Paraneoplasticsyndrome

    Signs of endocrinedisorder

    Depends on hormonebeing secreted

    Signs of metastasisdepends on site

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    65/123

    Chest X-rays Bronchoscopy Pulmonary function tests

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    66/123

    Surgery on localizedlesions Chemotherapy and

    radiation

    Poor prognosis unlesstumor in early stages

    of development

    Wh t i t b l i (TB)?

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    67/123

    What is tuberculosis (TB)?

    Tuberculosis (TB) is a disease caused bybacteria called Mycobacterium tuberculosis.

    The TB bacteria can affect any part of the

    body, but usually affects the lungs. If not treated properly, a person who has TB

    infection can develop TB disease.

    If a person develops TB disease and does

    not get appropriate medical treatment he/she

    can die.

    H d t TB?

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    68/123

    How do you get TB?

    TB is generally spread through the airwhen a person who has TB diseasefrequently sneezes, coughs, speaks or

    sings near others for a long period of time.Persons who breathe in air containingTB germs can become infected with TB.Typically, only close contacts of a

    person who has TB disease areconsidered to be at risk.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    69/123

    Mycobacterium tuberculosis

    Chronic granulomatous inflammation with

    caseous necros

    Pathogenesis

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    70/123

    Pathogenesis

    How is TB infection different

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    71/123

    How is TB infection different

    from TB disease?

    People with TB infection have a positive

    TB skin test but they: are not sick, do not

    have symptoms, cannot spread TB to others,can develop TB disease if not treated for

    TB infection.

    When TB infection is treated it greatlyreduces the chance that you will ever develop

    TB disease.

    How do I get tested for TB?

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    72/123

    How do I get tested for TB?

    A TB skin test is performed byinjecting a small amount of fluid in the skin on the

    lower part of the arm. You will need to return within

    48-72 hours to have a trained health care worker see if

    the skin test is positive or negative. You can get a skin test at your local health

    department or at your healthcare providers office.

    If you have a positive reaction to the skin test (TB

    infection), your healthcare provider may do other

    tests to see if you have developed TB disease.

    Wh t th t f TB?

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    73/123

    What are the symptoms of TB?

    Symptoms of TB disease include:feelings of sickness or weakness,

    weight loss, fever, and night sweats.

    When TB disease affects the lungs,additional symptoms may include: a bad

    cough that lasts longer than 2 weeks,

    shortness of breath, pain in the chest andcoughing up blood.

    Remember

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    74/123

    Remember

    TB infection occurs when a person hasbreathed in the TB germ, but the person is not

    sick.

    TB disease can develop in a person withTB infection if they do not get medical

    treatment.

    A person with TB disease is sick and mayhave several symptoms of the disease.

    If left untreated, persons with TB disease

    can die from TB.

    How is TB treated?

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    75/123

    How is TB treated?

    TB disease can usually be curedby taking several medicines for 6-12 months. It is very important that people who have TBdisease take the medication exactly as

    prescribed. If you stop taking the medication too soon,you can become sick again. Also, if you do not take the medicationcorrectly, the germs may become resistant tothose medications and become more difficult totreat.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    76/123

    An inflammation of the larynx.

    It causes hoarse voice or the

    complete loss of the voicebecause of irritation to thevocal folds.

    Bronchitis

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    77/123

    BronchitisBronchitis is an inflammation of the main airpassages to the lungs

    Most prevalent in winter

    Generally part of an acute URIIt may develop after a common cold orother viral infection of the nasopharynx,

    throat, or bronchi

    Often with secondary bacterial infection

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    78/123

    1.Malaise

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    79/123

    . a a se2.Chilliness

    3.Slight fever4.Back and muscle pain

    5.Sore throat6.Onset of a distressingcough usually signals

    onset of bronchitis7.Cough starts off dry and

    later produces mucous.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    80/123

    Tonsillitis

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    81/123

    Tonsillitis

    What is tonsillitis?

    Tonsillitis is a viral or bacterial infection inthe throat that causes inflammation of the

    tonsils. Tonsils are small glands (lymphoid

    tissue) in the pharyngeal cavity.

    In the first six months of life tonsilsprovide a useful defense against

    infections. Tonsillitis is one of the mostcommon ailments in pre-school children,

    but it can also occur at any age.

    Tonsillitis

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    82/123

    Tonsillitis

    Palatinetonsils

    (Visible duringoralexamination)

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    83/123

    Tonsillitis: Children are most often

    affected from around the

    age of three or four, when

    they start nursery or

    school and come intocontact with many new

    infections.

    A child may have tonsillitis ifhe/she has a sore throat, a fever

    and is off food.

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    84/123

    Tonsillitis is caused by a variety of

    contagious viral and bacterial

    infections. It is spread by close

    contact with other individuals and

    occurs more during winter

    periods. The most common

    bacterium causing tonsillitis is

    streptococcus.

    Otitis media

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    85/123

    Otitis media

    Background:

    Otitis media (OM) is the second most

    common disease of childhood, after upper

    respiratory infection (URI).

    Definition:

    Otitis media is an inflammation of the middleear.

    Otitis media:

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    86/123

    Otitis media:

    Otitis media can be classified into many

    variants on the basis of etiology,duration, symptomatology, and physical

    findings as the following:

    Acute Otitis media: implies rapid onsetof disease associated with 1 or more ofthe following symptoms:

    Otalgia, Fever, Otorrhea, Recent onset ofanorexia, Irritability, Vomiting, &

    Diarrhea

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    87/123

    Acute Otitis media (AOM):These symptoms are

    accompanied by abnormal

    otoscopic findings of the

    tympanic membrane (TM),

    which may include thefollowing:

    - Opacity

    - Bulging

    - Erythema

    - Middle ear effusion (MEE)

    http://www.emedicine.com/ped/images/Large/1784NEWNormal_TM_2.jpg
  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    88/123

    Healthy Tympanic

    Membrane

    http://www.emedicine.com/ped/images/Large/1784NEWNormal_TM_2.jpg
  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    89/123

    1.Administration ofantibiotic

    (Ampicillin or

    Amoxicillin) & anti-inflammatory

    (analgesic &

    antipyretic).

    Croup Syndrome:

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    90/123

    Croup Syndrome:Acute infection of the

    larynx characterized by severe

    involvement of voice & breathing appears

    in the following clinical pictures:hoarseness of voice, resonant cough, &

    varying degrees of respiratory distress.

    Croup syndromes are usually describedaccording to primary anatomic area

    affected e.g., laryngitis,

    laryngotracheobronchitis (LTB).

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    91/123

    - Therapeutic management:1. Hospitalization for

    continuous observation &

    for possible tracheostomy

    or endotracheal intubation.

    2. Provide cool mist oxygen.3. Patients may respond to

    corticosteroid therapy.

    The disease is usually selflimited.

    Home care:

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    92/123

    Home care:1. Encourage bed rest.2. Provide warm, high humidity

    atmosphere, especially

    during periods of coughing &

    during sleep.3. Encourage inhalation of

    warm steam to prevent

    recurrence.

    4. Keep the child calm most oftime (avoid crying, &

    excessive talking).

    Bronchiolitis:B hi liti i ill

    http://www.kidshealth.org/parent/general/body_basics/lungs.html
  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    93/123

    Bronchiolitis is a common illness

    of the respiratory tract usually

    caused by viral infection. Itaffects the tiny airways, called

    the bronchioles, that lead to the

    lungs. As these airways become

    inflamed, they swell and fill withmucus, making breathing

    difficult.

    The variable degrees of

    obstruction produced in airpassage by these changes lead

    to hyperpnoea & progressive

    emphysema.

    http://www.kidshealth.org/parent/general/body_basics/lungs.htmlhttp://www.kidshealth.org/parent/general/body_basics/lungs.html
  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    94/123

    Normal lungs

    & alveoli

    Bronchiolitis:- Incidence:

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    95/123

    - Incidence:

    - Typically occurs during the first 2years of life, with peak occurrence

    at about 3 to 6 months of age.

    - Is more common in males,

    children who have not beenbreastfed, and those who live in

    crowded conditions.

    -Day-care attendance and

    exposure to cigarette smoke also

    can increase the likelihood that an

    infant will develop bronchiolitis.

    Bronchiolitis:

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    96/123

    Bronchiolitis:- Nursing Assessment (S &

    S):

    The first symptoms of bronchiolitis

    are usually the same as those of

    a common cold:

    -Stuffiness runny nose, mild

    cough, &mild fever

    These symptoms last a day or two

    and are followed by worsening of

    the cough and the appearance of

    wheezes (high-pitched whistling

    noises when exhaling).

    http://www.kidshealth.org/parent/infections/common/cold.htmlhttp://www.kidshealth.org/parent/infections/common/cold.html
  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    97/123

    Bronchiolitis: Diagnostic evaluation:

    - Chest X-ray.

    - Culture from respiratory

    secretions.

    Therapeutic management:

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    98/123

    Therapeutic management:

    Fortunately, most cases of

    bronchiolitis are mild andrequire no specific treatment.

    Antibiotics aren't useful

    because bronchiolitis

    is caused by a viral infection.

    Medication may sometimes be

    given to help open a child's

    airways e.g., bronchodilators,corticosteroids.

    Cough suppressants.

    Encourage bed rest.

    Secondary bacterialinfection

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    99/123

    infection Obstruct drainage in 1 or

    more paranasal sinuses

    Common causativeorganisms Pneumococci Streptococci Haemophilus influenzae

    Exudate accumulates Signs Nasal congestion, fever,

    sore throat

    Diagnosis confirmed byradiograph, transillumination

    Decongestants, analgesics Antibiotics

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    100/123

    Naso-pharyngitis: =

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    101/123

    Naso-pharyngitis: =Common cold.

    Def:

    Viral infection of the nose& throat.

    Assessment (S &S):

    1.

    Younger childFever, sneezing, irritability,

    vomiting & diarrhea

    2. Olderchild

    Dryness & irritation of nose &throat, sneezing, &muscular aches.

    Complications of

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    102/123

    Complications of

    nasopharyngitis:

    - Otitis media- Lower respiratory tractinfection

    - Older child may developsinusitis

    Medication:Acetaminophen

    Pharyngitis:=Sore

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    103/123

    y g

    throat including tonsils.

    - Uncommon in childrenunder 1 yr. The peak

    incidence occurring

    between 4 & 7 yrs of age.

    - Causative organism:virusesorbacterial (group A beta-hemolytic streptococcus).

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    104/123

    Assessment (S &S)

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    105/123

    of pharyngitis:

    1.

    Younger child

    Fever, anorexia, general malaise, &

    dysphage

    2. Older

    child

    Fever (40 c), anorexia, abdominal

    pain, vomiting, & dysphagea.

    Complications ofpharyngitis:

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    106/123

    pharyngitis:

    - Retro pharyngeal abscess.- Otitis media.- Lower respiratory tract

    infection.

    - Complications of GABHSInfection: Peritonsillarabscess; occurs in fewer

    than 1% of patients treated

    with antibiotics that leads to

    rheumatic fever, oracute

    glomerulonephritis.

    Symptoms of influenza

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    107/123

    Symptoms of influenzainfection:

    Headache

    Fever, chills Muscle aches Nasal discharge Unproductive cough Sore throat

    Influenza infection can causemarked inflammation of therespiratory epithelium and a loss ofciliated cells that protect therespiratory passages from otherorganisms.

    As a result, influenza infection may

    lead to co-infection of the respiratorypassages with bacteria. It is also possible for the influenza

    virus to infect the tissues of the lungitself to cause a viral pneumonia.

    Treatment of influenza: Bed rest, fluids, warmth

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    108/123

    , ,

    Antiviral drugs

    Influenza vaccine :

    Provides protection against certainA and B influenza strains that areexpected to be prevalent in acertain year.

    The vaccine must be updated andadministered yearly to be effectivebut will not be effective againstinfluenza strains not included in thevaccine.

    The influenza vaccine is advisedfor elderly people, in individualsweakened by other disease and inhealth-care workers

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    109/123

    Carcinoma of theL

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    110/123

    Larynx

    Common Mostly in malesmokers over 40

    Alcohol abuseincreases the risk Presents with

    hoarseness pain cough dysphagia hemoptysis

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    111/123

    Restrictive LungDi

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    112/123

    Disease

    Chronic inflammationmaking lungs stiff &inelastic

    Affects diffusion Scar tissue accumulates

    in the interstitium Mostly cause is

    unknown

    Equal decline in FEV1 &FVC

    Usually presents withshortness of breath Can lead to pulmonary

    HTN

    Interstitial Fibrosis withoutGranulomatous Inflammation

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    113/123

    G a u o atous a at o

    Usually middle-agedmen at time ofdiagnosis

    Shortness of breath;may progress to corpulmonale, hypoxia

    Pneumoconioses black lung disease silicosis

    most commonchronicoccupationaldisease

    asbestosis mesothelioma

    Interstitial Fibrosis with

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    114/123

    Interstitial Fibrosis with

    Granulomatous Inflammation

    Sarcoidosis

    cause unknown

    affects many tissues butmostly lungs

    present with shortness of

    breath, cough, chest pain,hemoptysis

    Pulmonary Edema

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    115/123

    Pulmonary Edema

    Fluid in alveoli Increased BP in lung normal is 25/8 mmHg

    with average at 15 mmHg

    Microvascular injury due to

    toxic fumes hot gases septicemia IV drug abuse

    Main symptom is SOB

    PulmonaryThromboembolism

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    116/123

    Thromboembolism

    About 50,000 deaths annually Mostly from DVT Inflammation predisposes you to

    it

    Promoted by

    CHF pregnancy birth control pills prolonged bed rest metastatic cancer

    genetics Most associated with nosymptoms but some cause lung infarcts chest pain & dyspnea death

    Pulmonary Hypertension

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    117/123

    y yp Sustained systolic pressure over 30

    mmHg or average in excess of 25mmHg

    Vicious cycle Most common cause is increased

    pulmonary vascular resistance

    Usually secondary to

    COPD heart disease collagen vascular diseases recurrent pulmonary

    thromboemboli

    With R heart failure is cor pulmonale Thickening of arteriolar walls SOB

    chest pain fatigue

    Adult Respiratory Distress Syndrome

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    118/123

    ARDS Alveolar or pulmonary capillary damage Pathogenesis

    injury to endothelium or alveoli neutrophils infiltrate protein-rich fluid exudes into alveolar space SOB occurs with rapid breathing which dries the fluid into a thick

    membrane stiffens lungs limits airflow & interferes with diffusion hypoxia 50% fatality

    Causes sepsis smoke inhalation near drowning

    O2 toxicity burns DIC fat embolism endotoxic shock

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    119/123

    Lung Abscess

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    120/123

    Purulentinflammation withtissue necrosis &liquefaction

    Usually haveseveral types ofbacteria withanaerobic

    Most commonly dueto aspiration ofgastric contents

    Foul-smellingsputum

    Mostly due to

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    121/123

    y

    metastasis

    Bronchogeniccarcinoma is the most

    common

    most common of allcancers#1 cancer death

    about 90% arecigarette smokers

    Bronchogenic Carcinoma

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    122/123

    Bronchogenic Carcinoma

    Mostly caused by cigarettes Direct relationship between incidence of

    cancer & number of cigarettes smoked

    Direct relationship between precancerous

    changes in bronchial mucosa & number of

    cigarettes smoked

  • 7/29/2019 respiratory dis. Presentation1 for gen path.pptx

    123/123


Recommended